» Authors » Ajay Manhapra

Ajay Manhapra

Explore the profile of Ajay Manhapra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 988
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sellinger J, Rosen M, Lazar C, Gilstad-Hayden K, Dziura J, Li F, et al.
Pain Med . 2024 Nov; 25(Supplement_1):S99-S106. PMID: 39514877
Background: Veterans transitioning to civilian life often have chronic pain from service-related musculoskeletal disorders (MSD) with higher risk for substance misuse. Many seek VA (Department of Veterans Affairs) compensation for...
2.
McGeary D, Swan A, Kennedy E, Dismuke-Greer C, McGeary C, Sico J, et al.
NeuroRehabilitation . 2024 Oct; 55(3):303-317. PMID: 39422976
Background: Chronic headache after traumatic brain injury (TBI) is a common, yet disabling, disorder whose diverse clinical characteristics and treatment needs remain poorly defined. Objective: To examine diagnostic coding patterns...
3.
Kennedy E, Manhapra A, Miles S, Martindale S, Rowland J, Mobasher H, et al.
J Neurotrauma . 2024 Jun; PMID: 38907690
U.S. Service members and Veterans (SM/V) experience elevated rates of traumatic brain injury (TBI), chronic pain, and other non-pain symptoms. However, the role of non-pain factors on pain interference levels...
4.
Manhapra A, MacLean R, Rosenheck R, Becker W
Br J Clin Pharmacol . 2023 Nov; 90(12):2962-2976. PMID: 37990580
A re-examination of clinical principles of long-term opioid therapy (LTOT) for chronic pain is long overdue amid the ongoing opioid crisis. Most patients on LTOT report ineffectiveness (poor pain control,...
5.
Manhapra A, Zhou B, Rhee T, Rosenheck R
J Affect Disord . 2023 Oct; 344:585-591. PMID: 37863364
Background: Chronic pain and non-substance use psychiatric disorders (PD) are common comorbidities, both associated with impaired functioning. However, whether and how the prevalence of pain differs in remitted PD compared...
6.
Jegede O, Manhapra A, Zhou B, Rhee T, Rosenheck R
J Dual Diagn . 2023 Oct; 19(4):231-239. PMID: 37796996
Objective: There is limited information on the differences in the association of substance use disorders (SUD) with four clinically relevant hierarchical groups based on trauma exposure and its consequences (1-no...
7.
Gordon A, Saxon A, Kertesz S, Wyse J, Manhapra A, Lin L, et al.
Drug Alcohol Depend . 2023 May; 248:109902. PMID: 37196572
Background: Retention of patients in buprenorphine medication treatment for opioid use disorder (B-MOUD) reduces harms associated with opioid use disorder (OUD). We sought to characterize the patients receiving B-MOUD and...
8.
Manhapra A, Fortinsky R, Berg K, Ross J, Rhee T
J Gerontol A Biol Sci Med Sci . 2023 Apr; 78(9):1627-1640. PMID: 37096328
Background: There is limited knowledge on whether and how health care access restrictions imposed by the coronavirus disease of 2019 pandemic have affected utilization of both opioid and nonpharmacological treatments...
9.
Manhapra A
Pain . 2023 Feb; 164(3):e174. PMID: 36779559
No abstract available.
10.
Manhapra A
Curr Treat Options Oncol . 2022 Apr; 23(7):921-935. PMID: 35435616
Long-term opioid therapy (LTOT) for chronic cancer and non-cancer pain is commonly ineffective in providing its stated goal of improving function through good control of pain. Opioid tapering (slow dose...